Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fluidigm Corp (FLDM)

Fluidigm Corp (FLDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 457,274
  • Shares Outstanding, K 74,963
  • Annual Sales, $ 138,140 K
  • Annual Income, $ -53,020 K
  • 60-Month Beta 1.59
  • Price/Sales 3.29
  • Price/Cash Flow N/A
  • Price/Book 3.70
Trade FLDM with:

Options Overview

Details
  • Implied Volatility 70.20%
  • Historical Volatility 57.16%
  • IV Percentile 3%
  • IV Rank 2.00%
  • IV High 287.72% on 06/19/20
  • IV Low 65.75% on 05/28/21
  • Put/Call Vol Ratio 0.18
  • Today's Volume 236
  • Volume Avg (30-Day) 736
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 21,432
  • Open Int (30-Day) 27,613

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.04 +21.03%
on 05/14/21
6.18 -1.29%
on 06/11/21
+0.61 (+11.11%)
since 05/11/21
3-Month
4.03 +51.36%
on 05/07/21
6.18 -1.29%
on 06/11/21
+1.59 (+35.25%)
since 03/11/21
52-Week
3.36 +81.55%
on 06/25/20
12.45 -51.00%
on 08/26/20
+2.62 (+75.29%)
since 06/11/20

Most Recent Stories

More News
Next-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of Ownership

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of CyTOF XT, designed to simplify...

FLDM : 6.10 (+0.49%)
Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid Arthritis

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAMIN-GO Project...

FLDM : 6.10 (+0.49%)
Fluidigm to Present at Upcoming Investor Conferences

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company's management will participate...

FLDM : 6.10 (+0.49%)
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will host a virtual investor event...

FLDM : 6.10 (+0.49%)
Fluidigm: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Fluidigm Corp. (FLDM) on Thursday reported a loss of $18.8 million in its first quarter.

FLDM : 6.10 (+0.49%)
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period

Forecasting underlying base business growth of 16-17% supported by new product innovation

FLDM : 6.10 (+0.49%)
Fluidigm Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Fluidigm Corp. (NASDAQ:FLDM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 5:00 PM Eastern Time....

FLDM : 6.10 (+0.49%)
Data Published in Nature Communications Demonstrate the Power of Fluidigm's CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of data that further validate...

FLDM : 6.10 (+0.49%)
The Need for Comprehensive Diagnostics Remains as Cases Spike Once More

, /PRNewswire/ -- The Director of the U.S. National Institute of Allergy and Infectious Diseases, Dr. , and many other experts have warned that rapid reopening and lifting of pandemic restrictions in...

FLDM : 6.10 (+0.49%)
VXRT : 8.74 (+21.90%)
SBFM : 0.1275 (-2.82%)
BNTX : 238.55 (-0.53%)
VIR : 45.53 (-1.94%)
RNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 | Increasing Demand for Precision Medicines And Growing Investment are Major Factors Fueling Industry Growth, says Emergen Research

The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Some key...

FLDM : 6.10 (+0.49%)
ILMN : 453.17 (+0.55%)
MKKGY : 37.5900 (-1.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC);...

See More

Key Turning Points

3rd Resistance Point 6.37
2nd Resistance Point 6.27
1st Resistance Point 6.19
Last Price 6.10
1st Support Level 6.01
2nd Support Level 5.91
3rd Support Level 5.83

See More

52-Week High 12.45
Fibonacci 61.8% 8.98
Fibonacci 50% 7.90
Fibonacci 38.2% 6.83
Last Price 6.10
52-Week Low 3.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar